Author Summary
SGLT2 Inhibitors Cut Liver Fat in MASLD
Effect of SGLT2 inhibitors on liver fat content: A meta-analysis A growing metabolic challenge Metabolic dysfunction–associated steatotic liver disease (MASLD)—formerly called non-alcoholic fatty liver disease (NAFLD)—now affects about one-third of the global population. Like NAFLD, […]
